Restricting the choice of flavoured vapes, also known as e-cigarettes, could have an adverse effect on the many adults who use them to reduce or quit smoking, according to a new University of Bristol-led study published in the journal Harm Reduction.
A new study, the largest of its kind, published in Biological Psychiatry today [12 June], tracked the blood test results of over 3,500 participants for a span of 17 years to explore a possible link between diet and mental health.
People who experience an arterial ischemic stroke (AIS) or transient ischemic stroke (TIA) are at an increased risk of suffering a second stroke or other major adverse cardiovascular event (MACE), making it critically important to identify risk factors and treatments to prevent these subsequent occurrences. The new study, led by Boston University School of Public Health (BUSPH) and University of Bristol researchers, has identified new genetic and molecular risk factors that may reveal new pathways for treating patients after they experience their first stroke.
Children exposed to the anti-seizure drug lamotrigine during pregnancy were at no increased risk for autism or intellectual disability than those exposed to other anti-seizure medications, according to a new study on the use of eight different anti-seizure drugs published in Nature Communications today [15 November].
A new study has shown the benefit of using a quick clinic-based diagnostic test for hepatitis C virus (HCV) infection over a standard laboratory-based test. The findings from the study has led to World Health Organization (WHO) guidelines recommending the adoption of the point-of-care (POC) HCV test.
A new study that examined health data on 18 million people reveals higher incidence of mental illnesses for up to a year following severe COVID-19 in unvaccinated people. Vaccination appeared to mitigate the adverse effects of COVID-19 on mental illnesses. The University of Bristol-led study, published in JAMA Psychiatry today [21 August], investigated associations of COVID-19 with mental illnesses according to time since diagnosis and vaccination status.
Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind today. The latest findings from the ProtecT trial, led by the Universities of Bristol and Oxford, are presented today [12 March] at the European Association of Urology (EAU) Congress in Milan and published in the New England Journal of Medicine.
Culturally appropriate women-centred interventions can help healthcare systems respond to domestic violence, research has found. HERA (Healthcare Responding to Violence and Abuse) has been co-developing and evaluating a domestic violence and abuse healthcare intervention in low- and middle-income countries for the past five years. This National Institute for Health and Care Research (NIHR) Global Research Group will report their findings, and publish a PolicyBristol report, at a conference in London today [27 November].
Low back pain affects many people in the UK, restricting their daily activities and accounting for 5 per cent of GP appointments. Researchers from the University of Bristol, UWE Bristol and St George’s University Hospital NHS Foundation Trust, in collaboration with the Bristol, North Somerset, South Gloucestershire Integrated Care Board and getUBetter, have secured funding of over £1.3 million to evaluate the implementation of the musculoskeletal self-management app, getUBetter.
Self-harm remains neglected worldwide, with at least 14 million episodes yearly. A new Lancet Commission, led by University of Bristol researchers, urges policy action on societal drivers and health services’ response to this pressing issue. The report, involving an international team of experts, is published today [9 October].
